The estimated Net Worth of Bret Schwartzhoff is at least 633 千$ dollars as of 7 November 2017. Mr. Schwartzhoff owns over 9,500 units of Apollo Endosurgery Inc stock worth over 156,310$ and over the last 8 years he sold APEN stock worth over 0$. In addition, he makes 476,556$ as Vice President - North America Sales and Global Marketing at Apollo Endosurgery Inc.
Bret has made over 1 trades of the Apollo Endosurgery Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he bought 9,500 units of APEN stock worth 40,280$ on 7 November 2017.
The largest trade he's ever made was buying 9,500 units of Apollo Endosurgery Inc stock on 7 November 2017 worth over 40,280$. On average, Bret trades about 1,188 units every 0 days since 2016. As of 7 November 2017 he still owns at least 15,631 units of Apollo Endosurgery Inc stock.
You can see the complete history of Mr. Schwartzhoff stock trades at the bottom of the page.
Bret Schwartzhoff serves as Vice President - North America Sales and Global Marketing of the Company. Since December 2017, Mr. Schwartzhoff has served as Vice President, North America Sales and Global Marketing of Apollo, previously holding positions of Vice President of U.S. Sales and Global Marketing from December 2016 to December 2017, and from December 2014 to December 2015, he served as Apollo's Vice President U.S. Sales. From 2011 to 2014, Mr. Schwartzhoff served as Vice President of Marketing, Sports Medicine at ArthroCare Corporation and Smith & Nephew plc, which acquired ArthroCare, both medical device companies. Mr. Schwartzhoff holds a B.S. in Business from Mankato State University and an M.B.A. from Wake Forest University.
As the Vice President - North America Sales and Global Marketing of Apollo Endosurgery Inc, the total compensation of Bret Schwartzhoff at Apollo Endosurgery Inc is 476,556$. There are 3 executives at Apollo Endosurgery Inc getting paid more, with Christopher Gostout having the highest compensation of 1,156,870$.
Bret Schwartzhoff is 48, he's been the Vice President - North America Sales and Global Marketing of Apollo Endosurgery Inc since 2017. There are 16 older and 1 younger executives at Apollo Endosurgery Inc. The oldest executive at Apollo Endosurgery Inc is Dr. Christopher J. Gostout, 70, who is the Co-Founder & Chief Medical Officer.
Bret's mailing address filed with the SEC is 1120 S Capital of Texas Hwy #300, Austin, TX 78746, USA.
Over the last 12 years, insiders at Apollo Endosurgery Inc have traded over 3,882,241$ worth of Apollo Endosurgery Inc stock and bought 10,717,094 units worth 45,588,363$ . The most active insiders traders include Holdings A/S Novo、Neil Gagnon、R Kent Jr Mc Gaughy. On average, Apollo Endosurgery Inc executives and independent directors trade stock every 41 days with the average trade being worth of 2,726,880$. The most recent stock trade was executed by Jeffrey G. Black on 25 February 2022, trading 40,000 units of APEN stock currently worth 229,200$.
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
Apollo Endosurgery Inc executives and other stock owners filed with the SEC include: